188 related articles for article (PubMed ID: 22014019)
1. The role of human defensins in gastrointestinal diseases.
Langhorst J; Choi KE
Expert Rev Clin Immunol; 2011 Nov; 7(6):779-87. PubMed ID: 22014019
[TBL] [Abstract][Full Text] [Related]
2. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.
Kraneveld AD; Rijnierse A; Nijkamp FP; Garssen J
Eur J Pharmacol; 2008 May; 585(2-3):361-74. PubMed ID: 18417115
[TBL] [Abstract][Full Text] [Related]
3. Paneth cell defensins: key effector molecules of innate immunity.
Bevins CL
Biochem Soc Trans; 2006 Apr; 34(Pt 2):263-6. PubMed ID: 16545089
[TBL] [Abstract][Full Text] [Related]
4. Defensin-immunology in inflammatory bowel disease.
Wehkamp J; Stange EF; Fellermann K
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity.
Auvynet C; Rosenstein Y
FEBS J; 2009 Nov; 276(22):6497-508. PubMed ID: 19817855
[TBL] [Abstract][Full Text] [Related]
6. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
7. Innate antimicrobial immunity in inflammatory bowel diseases.
Beisner J; Stange EF; Wehkamp J
Expert Rev Clin Immunol; 2010 Sep; 6(5):809-18. PubMed ID: 20828289
[TBL] [Abstract][Full Text] [Related]
8. Innate and adaptive immunity in inflammatory bowel diseases.
Foersch S; Waldner MJ; Neurath MF
Dig Dis; 2013; 31(3-4):317-20. PubMed ID: 24246981
[TBL] [Abstract][Full Text] [Related]
9. [Defensins: endogenous antibiotics as a central part of innate immunity].
Kübler I; Stange EF; Fellermann K; Wehkamp J
Dtsch Med Wochenschr; 2006 Sep; 131(36):1960-4. PubMed ID: 16967396
[No Abstract] [Full Text] [Related]
10. Review: Defensins and cathelicidins in lung immunity.
Tecle T; Tripathi S; Hartshorn KL
Innate Immun; 2010 Jun; 16(3):151-9. PubMed ID: 20418263
[TBL] [Abstract][Full Text] [Related]
11. Altered peripheral toll-like receptor responses in the irritable bowel syndrome.
McKernan DP; Gaszner G; Quigley EM; Cryan JF; Dinan TG
Aliment Pharmacol Ther; 2011 May; 33(9):1045-52. PubMed ID: 21453321
[TBL] [Abstract][Full Text] [Related]
12. Is irritable bowel syndrome a low-grade inflammatory bowel disease?
Bercik P; Verdu EF; Collins SM
Gastroenterol Clin North Am; 2005 Jun; 34(2):235-45, vi-vii. PubMed ID: 15862932
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of toll-like receptors in patients with irritable bowel syndrome.
Brint EK; MacSharry J; Fanning A; Shanahan F; Quigley EM
Am J Gastroenterol; 2011 Feb; 106(2):329-36. PubMed ID: 21102570
[TBL] [Abstract][Full Text] [Related]
14. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
15. Defensins and other antimicrobial peptides in inflammatory bowel disease.
Wehkamp J; Schmid M; Stange EF
Curr Opin Gastroenterol; 2007 Jul; 23(4):370-8. PubMed ID: 17545771
[TBL] [Abstract][Full Text] [Related]
16. Innate and adaptive immune connections in inflammatory bowel diseases.
Rakoff-Nahoum S; Bousvaros A
Curr Opin Gastroenterol; 2010 Nov; 26(6):572-7. PubMed ID: 20871398
[TBL] [Abstract][Full Text] [Related]
17. Defensins in the oral cavity: distribution and biological role.
Gomes Pde S; Fernandes MH
J Oral Pathol Med; 2010 Jan; 39(1):1-9. PubMed ID: 19895659
[TBL] [Abstract][Full Text] [Related]
18. Defensins: antimicrobial peptides of innate immunity.
Ganz T
Nat Rev Immunol; 2003 Sep; 3(9):710-20. PubMed ID: 12949495
[TBL] [Abstract][Full Text] [Related]
19. Innate defenses of the intestinal epithelial barrier.
Müller CA; Autenrieth IB; Peschel A
Cell Mol Life Sci; 2005 Jun; 62(12):1297-307. PubMed ID: 15971105
[TBL] [Abstract][Full Text] [Related]
20. Irritable bowel syndrome: towards biomarker identification.
Clarke G; Quigley EM; Cryan JF; Dinan TG
Trends Mol Med; 2009 Oct; 15(10):478-89. PubMed ID: 19811951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
